Table 1 Expression pattern of survivin, p53 and Bcl-2 in liver metastases pre- and post - 90 Y-RE
Biomarkers | Number of patients (%) | |
|---|---|---|
Pre-90Y-RE (N = 29) | Post-90Y-RE (N = 15) | |
Survivin N (%) | ||
Negative (≤ 20) | 5 (16.2) | 10 (66.7) |
Positive (> 20) | 24 (77.4) | 5 (33.3) |
p53 N (%) | ||
Negative (≤ 10) | 2 (6.9) | 4 (26.7) |
Positive (> 10) | 27 (93.1) | 11 (73.3) |
Bcl-2 N (%) | ||
Negative (≤ 5) | 18 (62.1) | 11 (73.3) |
Positive (> 5) | 11 (37.9) | 4 (26.7) |
Ki-67 N (%) | ||
Negative (<50) | 11 (37.5) | 9 (60.0) |
Positive (≥ 50) | 18 (62.5) | 6 (40.0) |